Activating the brain’s immune system against the deadly cancer Glioblastoma prevents it from spreading – J-Wire Jewish Australian News Service

Groundbreaking research from Tel Aviv University may lead to a significant breakthrough in the battle against deadly brain cancer.
Prof. Ronit Satchi-Fainaro
To begin with, the researchers identified a failure in the brain’s immune system, leading to the amplification of cell division and spread of Glioblastoma cancer cells. The failure results partially from the secretion of a protein called P-Selectin (SELP), which, when bound to its receptor on the brain immune cells, alters their function so…

Click here to view the original article.